NDV-HXP-S
0 sources
NDV-HXP-S
Summary
NDV-HXP-S ranks in the top 2% of general entities by monthly Wikipedia readership (5 views/month).[1]
Key Facts
- NDV-HXP-S's image is recorded as Coletiva de imprensa para anúncio da Butanvac a vacina 100% nacional (51072730543).jpg[2].
- NDV-HXP-S's developer is recorded as Mount Sinai Hospital[3].
- NDV-HXP-S's developer is recorded as University of Texas at Austin[4].
- NDV-HXP-S's developer is recorded as National Institute of Allergy and Infectious Diseases[5].
- NDV-HXP-S's subclass of is recorded as COVID-19 vaccine[6].
- NDV-HXP-S's subclass of is recorded as viral vector vaccine[7].
- NDV-HXP-S's Commons category is recorded as ButanVac[8].
- NDV-HXP-S's described by source is recorded as Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate[9].
- NDV-HXP-S's Google Knowledge Graph ID is recorded as /g/11n2c82q5p[10].
Why It Matters
NDV-HXP-S ranks in the top 2% of general entities by monthly Wikipedia readership (5 views/month).[1] NDV-HXP-S has Wikipedia articles in 8 language editions, a strong signal of global cultural recognition.[11] NDV-HXP-S is known by 5 alternative names across languages and contexts.[12]